, Volume 7, Issue 2, pp 156–162 | Cite as

Evaluation of markers of inflammation, insulin resistance and endothelial dysfunction in children at risk for overweight

  • Gulcin Akinci
  • Baris AkinciEmail author
  • Senol Coskun
  • Petek Bayindir
  • Zeliha Hekimsoy
  • Bilgin Özmen
Research paper


Objective: Childhood obesity is associated with impaired endothelial function, insulin resistance and inflammation. Being at risk for overweight has been defined as having a body mass index (BMI) between the 85th and 94th percentile for age and sex. In this study, we looked for features linked to cardiovascular risk in children who are at risk for overweight. Design: Twenty-one children who were at risk for overweight (study group) and 20 children with a BMI between the 25th–74th percentiles (controls) were studied. Fasting blood levels of glucose, insulin, total cholesterol, HDL cholesterol, triglycerides, uric acid, fibrinogen and high sensitive C-reactive protein (CRP) were assessed in both groups. LDL-cholesterol, HOMA-IR and QUICKI indices were calculated. Flow-mediated Vasodilatation (FMD) was determined for the evaluation of endothelial function. Results: Increased HOMA-IR was observed in children who were at risk for overweight. Waist circumference was the main predictor of insulin resistance in these children. Higher levels of CRP were found in the study group compared to controls, while plasma fibrinogen did not differ in the two groups. The children who were at risk for overweight had lower FMD values and slightly elevated lipids compared to controls; however, these differences were not statistically significant. Conclusion: Insulin resistance and inflammation indices were higher in children who were at risk for overweight as has been shown for obese children. The data suggest that appropriate treatment strategies for weight control are essential not only for obese children but also for those at risk for overweight.

Key words

Overweight Atherosclerosis Flow mediated dilatation HOMA-IR C-reactive protein 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barlow SE, Dietz WH, 1998 Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. Pediatrics 102: E29.CrossRefPubMedGoogle Scholar
  2. 2.
    Weiss R, Dziura J, Burgert TS, et al, 2004 Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350: 2362–2374.CrossRefPubMedGoogle Scholar
  3. 3.
    U.S. Preventive Services Task Force, 2006 Screening and interventions for overweight in children and adolescents: recommendation statement. Am Fam Physician 73: 115–119.Google Scholar
  4. 4.
    Ogden CL, 2004 Defining overweight in children using growth charts. Md Med 5: 19–21.PubMedGoogle Scholar
  5. 5.
    Bundak R, Furman A, Gunoz H, et al, 2006 Body mass index references for Turkish children. Acta Paediatr 95: 194–198.CrossRefPubMedGoogle Scholar
  6. 6.
    Ells LJ, Campbell K, Lidstone J, et al, 2005 Prevention of childhood obesity. Best Pract Res Clin Endocrinol Metab 19: 441–454.CrossRefPubMedGoogle Scholar
  7. 7.
    Smoak CG, Burke GL, Webber LS, et al, 1987 Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults. The Bogalusa Heart Study. Am J Epidemiol 125: 364–372.CrossRefPubMedGoogle Scholar
  8. 8.
    Sinaiko AR, Steinberger J, Moran A, et al, 2006 Influence of insulin resistance and body mass index at age 13 on systolic blood pressure, triglycerides, and high-density lipoprotein cholesterol at age 19. Hypertension 48: 730–736.CrossRefPubMedGoogle Scholar
  9. 9.
    Sinaiko AR, Steinberger J, Moran A, et al, 2005 Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation 111: 1985–1991.CrossRefPubMedGoogle Scholar
  10. 10.
    Meyer AA, Kundt G, Steiner M, Schuff-Werner P, Kienast W, 2006 Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: the impact of cardiovascular risk factors. Pediatrics 117: 1560–1567.CrossRefPubMedGoogle Scholar
  11. 11.
    Ross R, 1986 The pathogenesis of atherosclerosis—an update. N Engl J Med 314: 488–500.CrossRefPubMedGoogle Scholar
  12. 12.
    Garanty-Bogacka B, Syrenicz M, Syrenicz A, Gebala A, Walczak M, 2005 Relation of acute-phase reaction and endothelial activation to insulin resistance and adiposity in obese children and adolescents. Neuro Endocrinol Lett 26: 473–479.PubMedGoogle Scholar
  13. 13.
    Park HS, Park JY, Yu R, 2005 Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 69: 29–35.CrossRefPubMedGoogle Scholar
  14. 14.
    Ridker PM, 2001 High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103: 1813–1818.CrossRefPubMedGoogle Scholar
  15. 15.
    Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB Sr, Wilson PW, 2004 C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110: 380–385.CrossRefPubMedGoogle Scholar
  16. 16.
    Koenig W, Sund M, Frohlich M, et al, 1999 C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99: 237–242.CrossRefPubMedGoogle Scholar
  17. 17.
    Zhu W, Huang X, He J, Li M, Neubauer H, 2005 Arterial intima-media thickening and endothelial dysfunction in obese Chinese children. Eur J Pediatr 164: 337–344.CrossRefPubMedGoogle Scholar
  18. 18.
    Clauss A, 1957 [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol 17: 237–246.CrossRefPubMedGoogle Scholar
  19. 19.
    Weiss R, Caprio S, 2005 The metabolic consequences of childhood obesity. Best Pract Res Clin Endocrinol Metab 19: 405–419.CrossRefPubMedGoogle Scholar
  20. 20.
    Hubert HB, Feinleib M, McNamara PM, Castelli WP, 1983 Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67: 968–977.CrossRefPubMedGoogle Scholar
  21. 21.
    Chew GT, Gan SK, Watts GF, 2006 Revisiting the metabolic syndrome. Med J Aust 185: 445–449.PubMedGoogle Scholar
  22. 22.
    Fontbonne AM, Eschwege EM, 1991 Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care 14: 461–469.CrossRefPubMedGoogle Scholar
  23. 23.
    Cook DG, Mendall MA, Whincup PH, et al, 2000 C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 149: 139–150.CrossRefPubMedGoogle Scholar
  24. 24.
    Ford ES, Galuska DA, Gillespie C, et al, 2001 C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988–1994. J Pediatr 138: 486–492.CrossRefPubMedGoogle Scholar
  25. 25.
    Kivimaki M, Lawlor DA, Juonala M, et al, 2005 Lifecourse socioeconomic position, C-reactive protein, and carotid intima-media thickness in young adults: the cardiovascular risk in Young Finns Study. Arterioscler Thromb Vasc Biol 25: 2197–2202.CrossRefPubMedGoogle Scholar
  26. 26.
    Radikova Z, 2003 Assessment of insulin sensitivity/resistance in epidemiological studies. Endocr Regul 37: 189–194.PubMedGoogle Scholar
  27. 27.
    Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C, 2005 Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 115: e500–503.CrossRefPubMedGoogle Scholar

Copyright information

© Hellenic Endocrine Society 2008

Authors and Affiliations

  • Gulcin Akinci
    • 1
  • Baris Akinci
    • 2
    Email author
  • Senol Coskun
    • 3
  • Petek Bayindir
    • 4
  • Zeliha Hekimsoy
    • 5
  • Bilgin Özmen
    • 5
  1. 1.Department of PediatricsCelal Bayar University Medical SchoolManisaTurkey
  2. 2.Division of Endocrinology and Metabolism, Department of Internal MedicineDokuz Eylul University Medical SchoolIzmirTurkey
  3. 3.Division of Pediatric Cardiology, Department of PediatricsCelal Bayar University Medical SchoolTurkey
  4. 4.Department of RadiologyCelal Bayar University Medical SchoolTurkey
  5. 5.Division of Endocrinology and Metabolism, Department of Internal MedicineCelal Bayar University Medical SchoolManisaTurkey

Personalised recommendations